Safety First Trust Principal-Protected Certificates Linked TO A U.S.-Europe-Japan Basket (ATA) 銘柄情報

good reading...

The Bennington Microtechnology Center (BMC), which is focused on the commercialization of sensors, announced at Sensors Expo 2007 that it has formed a Process Development Partnership with Apogee Technology.

The agreement provides Apogee with a manufacturing process design for their new Sensilica line of pressure sensors. This initial order includes design, development, and implementation of an assembly, packaging, and test process for Apogee's new line of pressure sensors. Included will be an initial pilot production run for process qualification and customer sampling.

we need to get everyone back for the NU$$$$$$.

where is everyone,this will run....

new symbol....ATCS..March 31,2008.

LOOK,LOOK.. NEW HAPPENINGS,Pay Attention All.

I received this yesterday and thought I would share...


Apogee Technology, Inc. (“Apogee”, Amex: ATA) is a biotechnology company based in Norwood, Massachusetts that is developing proprietary systems for the delivery of drugs into the skin for the treatment and prevention of local and systemic conditions. The Company’s PyraDerm™ intradermal delivery system incorporates an array of microneedles containing a solid-state macromolecular/drug formulation that dissolves in the skin releasing drugs to achieve optimal delivery performance. It is designed to be painless, low cost, self-administered and easily stored, all of which are important needs in the drug delivery market. The Company is also developing and commercializing sensors and sensor systems with a specialized focus on health monitoring.



Important accomplishments to date include:



* Development of PyraDerm™ prototypes and establishment of macromolecular formulation coating processes.
* Installation of internal formulation and analytical laboratories and hired leading scientists to develop our technologies.
* Validation (preliminary) of PyraDerm™ by researchers from Emory University who showed improved immune response with multiple vaccine antigens in animals compared to conventional drug delivery systems.
* Start of pre-clinical data package to enable the company to pursue its PyraDerm™ licensing and joint venture business strategy.
* Defined non-regulated PyraDerm™ delivery products.
* Multiple patents licensed and patent applications filed to protect our drug delivery technologies.
* Establishment of prestigious Scientific Advisory Board.
* Focused sensor business strategy to leverage our medical technology in the growing medical monitoring market.


For more information please visit our web site at: http://www.apogeebio.com.

way to go, two patents!

Press Release Source: Apogee Technology, Inc
Apogee Files Two U.S. Patent Applications Supporting Its Intradermal Drug Delivery System
Thursday July 19, 10:45 am ET
NORWOOD, MA--(MARKET WIRE)--Jul 19, 2007 -- Apogee Technology, Inc. (AMEX:ATA - News), a biotechnology company that develops drug delivery and sensor systems, announced today that it has filed two U.S. provisional patent applications relating to its intradermal drug delivery technology. The new patent applications describe advanced macromolecular formulations and coating methodologies.
Dr. Alexander K. Andrianov, Apogee's Vice President of Research and Development, said, "These filings are an important achievement of the company's ongoing research and development program and are intended to protect rights for formulations with improved coating efficiency, methods and systems for precise dose control. If issued, these patent applications will constitute an important contribution to our intellectual property position."
About Apogee Technology, Inc.
Apogee Technology designs, develops and commercializes proprietary drug delivery and sensor products using its MEMS and nanotechnology for its application markets. The Company is developing its PyraDerm(TM) solution for enhanced intradermal drug delivery and has introduced a family of pressure sensors under the Sensilica® brand. Apogee's goal is to provide value-added and cost-saving solutions for our customers and, in so doing, become a global leader in the drug delivery and sensor fields. For more information please visit our web site at: http://www.apogeebio.com.
PyraDerm(TM) and Sensilica® are trademarks of Apogee Technology, Inc. All other product names noted herein may be trademarks of their respective holders. Certain statements made herein that use the words "anticipate," "may," "hope," "estimate," "project," "will," "intend," "plan," "expect," "believe" and similar expressions are intended to identify forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve the design, development and production efforts of our PyraDerm(TM) and Sensilica® technologies, known and unknown risks and uncertainties, which could cause the actual results, performance or achievements of the Company to be materially different from those that may be expressed or implied. Please refer to the company's risk factors as set forth in the Company's filings with the Securities and Exchange Commission, including its reports on Forms 10-KSB, as amended, for the year ended December 31, 2006 and10-QSB for the quarter ended March 31, 2007.

Contact:
Apogee Investor Contact:
Kelly Black
Premier Funding & Financial Marketing
480-649-8224
Email Contact

Do you know when this new order will start coming out? I am interested to see how it effects the stocks, it hasn't been doing so well lately.

Most Recent Update:

The Bennington Microtechnology Center (BMC), which is focused on the commercialization of sensors, announced at Sensors Expo 2007 that it has formed a Process Development Partnership with Apogee Technology.

The agreement provides Apogee with a manufacturing process design for their new Sensilica line of pressure sensors. This initial order includes design, development, and implementation of an assembly, packaging, and test process for Apogee's new line of pressure sensors. Included will be an initial pilot production run for process qualification and customer sampling.

"Receiving this significant order from a major sensor company with an exciting new product validates again that our modular and flexible automated manufacturing process approach supports complex process development and is extensible to volume production," said Henry Klim, Executive Director of BMC. "During our evaluation phase, BMC was extremely supportive, providing a variety of options for assembly, packaging and test. In addition, BMC is providing a comprehensive Supply Chain Management approach to manufacturing...they are taking care of all of the procurement, assembly, packaging and test activities which will free us up for what we do best...design and develop sensors. We are truly excited about this partnership," said Dave Meyers, COO of Apogee Technology, Inc.

50 dma gonna cross the 200 quite soon, should see a jump over 1.50 shortly there after, IMO!

any new patents with this nantechnology?

You have to do some serious dd.They are now is a business that works.Welcome to the future.Throw away your comodore-64 and your old Atari.

just delete out the post and screen everyrthing

This site will be manipulated

They go from making $15,000 audi speakers to nanotechnology
with it's long history of losses be carefull(read the 10KSB)

hopefully they find away to compete in this market and develop new product lines.

With only 6 employees they better get crackin on some new technology.